-
TRUSTED AU LABORATORY
-
26 Mark Rd. Elizabeth South, SA - 5112
-
Same day delivery
Pull the syringe to:
(0.100ml)
This calculator is provided as a reference tool for research purposes only. Always follow your institution’s safety protocols when handling research compounds.
SLU-PP-332 5mg is a synthetic research compound studied in relation to estrogen-related receptor signalling, mitochondrial metabolism, oxidative energy pathways and exercise-mimetic research.
Although it may appear in peptide research catalogues, SLU-PP-332 is more accurately described as a small-molecule research compound rather than a peptide. It is commonly studied as a pan-estrogen-related receptor agonist, with activity across ERRα, ERRβ and ERRγ. Supplier and research references describe SLU-PP-332 as an ERR agonist with reported EC50 values in the nanomolar range for ERRα, ERRβ and ERRγ reporter systems.
This product is supplied for laboratory research use only. It is not a medicine, supplement, weight loss product, performance product, metabolic treatment, exercise replacement product or injectable product for human use.
| Product Detail | Information |
|---|---|
| Product name | SLU-PP-332 |
| Size | 5mg |
| Product type | Small-molecule research compound |
| Research category | Mitochondrial Research / Metabolic Research |
| Common research interest | ERR signalling, mitochondrial metabolism, exercise-mimetic research |
| Main target family | Estrogen-related receptors ERRα, ERRβ and ERRγ |
| Form | Research powder or supplier-specific preparation |
| Intended use | Laboratory research only |
| Human use | Not for human consumption, administration or injection |
| Documentation | Certificate of Analysis should be checked before use |
| Component | Research Class | General Research Role |
| SLU-PP-332 | Synthetic small-molecule compound | Studied as a pan-ERR agonist in metabolic and mitochondrial research |
| Chemical scaffold | Benzohydrazide / hydrazone-style small molecule | Associated with ERR activation research |
| Molecular formula | C18H14N2O2 | Listed in PubChem for SLU-PP-332 |
| Molecular weight | Approximately 290.3 g/mol | Useful for laboratory concentration and molar calculation planning |
| CAS number | 303760-60-3 | Common chemical registry identifier |
| Lyophilised or dry preparation | Supplier-specific research format | Supports storage before laboratory preparation when stored correctly |
PubChem lists SLU-PP-332 with the molecular formula C18H14N2O2, and chemical suppliers commonly identify it under CAS number 303760-60-3.
The exact product identity, purity and batch information should always be confirmed through the supplier documentation and Certificate of Analysis. Researchers should not rely on product name alone when confirming compound identity.
SLU-PP-332 is studied as an agonist of the estrogen-related receptor family. Estrogen-related receptors are nuclear receptors involved in the regulation of genes connected to mitochondrial function, oxidative metabolism and energy pathway signalling.
In preclinical research, SLU-PP-332 has been described as an exercise-mimetic research tool because it can activate transcriptional programmes associated with aerobic exercise biology in skeletal muscle models. A 2023 preclinical study reported that SLU-PP-332 increased mitochondrial function and cellular respiration in a skeletal muscle cell line, increased type IIa oxidative skeletal muscle fibres in mice and enhanced exercise endurance in mouse models.
This should be understood as research literature context only. It should not be promoted as a human exercise replacement, weight loss product, endurance product, metabolic therapy or performance enhancer.
| Research Area | SLU-PP-332 |
| Main research category | ERR agonist research |
| Primary receptor interest | ERRα, ERRβ and ERRγ |
| Research pathway | Nuclear receptor signalling |
| Mitochondrial interest | Oxidative metabolism and cellular respiration |
| Exercise-mimetic interest | Aerobic exercise-like gene expression in preclinical models |
| Metabolic interest | Energy expenditure, fatty acid oxidation and metabolic syndrome models |
| Evidence limitation | Mostly preclinical and laboratory research |
| Product limitation | Research use only, not approved for human use |
| ERR Target | Research Relevance |
| ERRα | Strongly linked to mitochondrial metabolism, skeletal muscle energy regulation and aerobic exercise-response research |
| ERRβ | Studied as part of the broader estrogen-related receptor family |
| ERRγ | Studied in energy metabolism, cardiac metabolism and oxidative pathway research |
| Pan-ERR activity | SLU-PP-332 is commonly discussed as a compound that can activate more than one ERR subtype |
SLU-PP-332 has also been examined in broader preclinical research areas, including obesity and metabolic syndrome models. A Journal of Pharmacology and Experimental Therapeutics article describes SLU-PP-332 as an ERRα, ERRβ and ERRγ agonist that activates an acute aerobic exercise programme and examines its effects in mouse models of obesity and metabolic syndrome.
| Common Online Claim | Safer Research-Use Wording |
| Exercise in a pill | Studied as an exercise-mimetic compound in preclinical models |
| Weight loss | Studied in mouse models of obesity and metabolic syndrome |
| More endurance | Studied in relation to skeletal muscle oxidative fibre and endurance models |
| Fat burning | Studied in relation to fatty acid oxidation and mitochondrial metabolism |
| Muscle performance | Studied in skeletal muscle gene expression and cellular respiration research |
| Anti-ageing | Not an approved or appropriate product claim |
| Human performance enhancement | Not an approved or appropriate product claim |
SLU-PP-332 5mg is not intended to diagnose, treat, cure or prevent any disease. It is not supplied for weight loss, exercise replacement, muscle growth, endurance, anti-ageing, recovery, performance enhancement, metabolic health, bodybuilding or general wellness use.
All information on this page is provided for laboratory research and product handling context only.
There is no universal recommended dilution for SLU-PP-332 5mg. Dilution depends on the research protocol, required working concentration, assay design, solvent compatibility, storage method and validated laboratory procedure.
Because SLU-PP-332 is a small-molecule research compound rather than a peptide, researchers should not assume that peptide-style reconstitution methods or water-based preparation methods are suitable. Solvent compatibility should be confirmed through the supplier Certificate of Analysis, SDS and validated laboratory protocol.
For research concentration planning only, the basic formula is:
Total compound amount divided by solvent volume equals final concentration.
| Solvent Added to 5mg Vial | Final Concentration |
| 0.5mL | 10mg/mL |
| 1mL | 5mg/mL |
| 2mL | 2.5mg/mL |
| 2.5mL | 2mg/mL |
| 5mL | 1mg/mL |
| 10mL | 0.5mg/mL |
These are research concentration examples only. They are not human dosing instructions and must not be used to calculate injection quantities.
Before handling SLU-PP-332 5mg in a laboratory setting, make sure all materials, documentation and clean handling conditions are prepared.
| Item | Purpose |
| Product vial | Contains SLU-PP-332 research compound |
| Certificate of Analysis | Confirms batch-level testing information |
| SDS or safety documentation | Provides hazard, handling and disposal guidance |
| Suitable research-grade solvent | Used to prepare a working laboratory solution if compatible |
| Sterile or clean lab consumables | Helps reduce contamination and cross-contamination risk |
| Personal protective equipment | Gloves, lab coat and eye protection |
| Approved disinfectant | Used for bench and handling area preparation |
| Laboratory labels | Records concentration, date, batch and handler details |
| Controlled storage access | Supports correct storage after preparation |
| Chemical waste container | Used for compliant laboratory waste disposal |
The following is a general laboratory handling framework only. Always follow the product Certificate of Analysis, supplier documentation, SDS, institutional procedures and validated research protocol.
Check the product label, batch number, Certificate of Analysis, SDS and storage requirements before handling the vial.
Use a clean laboratory workspace suitable for handling small-molecule research compounds. Wear appropriate PPE and disinfect the bench surface and required equipment.
Do not assume SLU-PP-332 is compatible with the same diluent used for peptides. Confirm the required research-grade solvent or vehicle through supplier documentation, SDS and the approved research protocol.
Add the selected research-grade solvent according to laboratory procedure. Avoid uncontrolled splashing, aerosol generation or unnecessary exposure.
Gently swirl, invert or mix according to the validated protocol until the compound is dissolved or suspended as required. Do not heat, sonicate or vortex unless the protocol specifically allows it.
Check the preparation for visible particles, cloudiness, unexpected precipitation, unusual colour changes or separation. If anything appears abnormal, quarantine the preparation and check supplier documentation.
Label the vial or aliquots with the product name, concentration, solvent used, date prepared, batch number and researcher initials.
Place the prepared solution into the required storage condition as soon as possible. Avoid unnecessary temperature cycling, light exposure or repeated freeze-thaw cycles.
Some small-molecule research compounds may not dissolve easily in water or peptide-style diluents. Solubility should always be handled according to validated laboratory protocol.
| Issue | What It May Indicate | Safer Response |
| Powder remains after mixing | Solvent may not be suitable | Check SDS and supplier solubility guidance |
| Cloudiness appears | Incomplete dissolution or incompatibility | Stop and review protocol |
| Precipitation occurs | Concentration may be too high or solvent unsuitable | Reassess working concentration and solvent |
| Colour change | Possible degradation or contamination | Do not continue without supplier guidance |
| Separation occurs | Vehicle incompatibility | Quarantine and review documentation |
| Storage Factor | Guidance |
| Product form | Dry research compound or supplier-specific preparation |
| Storage condition | Follow supplier label, CoA and SDS |
| Light exposure | Protect from unnecessary light exposure |
| Moisture exposure | Keep sealed until use |
| Temperature changes | Avoid repeated temperature cycling |
| Handling | Minimise unnecessary opening and exposure |
| Storage Factor | Guidance |
| Storage condition | Follow validated research protocol |
| Labelling | Record concentration, solvent, date and batch number |
| Freeze-thaw cycles | Avoid repeated freeze-thaw exposure where relevant |
| Aliquoting | Use small research aliquots where appropriate |
| Contamination control | Use clean laboratory technique |
| Light exposure | Protect from unnecessary light exposure if required |
| Disposal | Dispose according to chemical waste procedures |
Small-molecule research compounds may be sensitive to temperature, light, solvent conditions and contamination. Storage conditions should be confirmed through supplier documentation or the laboratory’s validated method.
This page does not provide human dosing, injection instructions, injection schedules or administration guidance.
SLU-PP-332 5mg is not supplied for human or animal administration. It is a laboratory research-use product only.
For research settings, any measured aliquots should be prepared according to the concentration required by the approved research protocol. All calculations should be checked, documented and traceable.
| Planning Item | What to Record |
| Final concentration | Total compound amount and solvent volume |
| Working solution | Concentration used in the research protocol |
| Aliquot volume | Volume transferred into each labelled lab container |
| Batch details | Product batch, CoA and preparation date |
| Solvent or vehicle | Exact solvent, percentage and preparation method |
| Storage location | Fridge, freezer, desiccator or other controlled storage area |
| Handler details | Researcher name or initials |
| Preparation date | Date and time of preparation |
| Disposal date | When the aliquot should no longer be used |
Correct handling is important for research consistency, contamination control, chemical safety and product traceability. Most mistakes occur when products are not labelled clearly, solubility is assumed, concentration calculations are not recorded or storage conditions are not followed.
| Always | Why It Matters |
| Check the Certificate of Analysis | Confirms batch-level information |
| Review the SDS | Supports safe chemical handling and disposal |
| Use PPE | Reduces exposure and contamination risk |
| Confirm solvent compatibility | Prevents failed preparation or invalid research results |
| Label every vial and aliquot | Prevents mix-ups |
| Record concentration calculations | Supports traceability |
| Use clean laboratory technique | Reduces contamination risk |
| Follow institutional protocols | Keeps handling consistent and auditable |
| Store according to documentation | Helps protect compound integrity |
| Dispose of chemical waste correctly | Supports safety and compliance |
| Never | Why It Is Risky |
| Never use for self-injection | Product is research use only |
| Never market it as exercise in a bottle | Creates misleading human-use and compliance risk |
| Never make weight loss or performance claims | Not an approved or appropriate product claim |
| Never assume water solubility | SLU-PP-332 is a small-molecule compound, not a standard peptide vial |
| Never assume purity without CoA | Batch quality must be documented |
| Never use a damaged or unlabelled vial | Identity and integrity may be uncertain |
| Never use random solvents | May damage the compound or invalidate research results |
| Never leave prepared solutions unlabelled | Creates traceability risk |
| Never rely on social media protocols | They may be inaccurate, unsafe or non-compliant |
The table below is for concentration planning only. It does not represent dosage, injection quantity or recommended administration.
| Total Vial Amount | Solvent Volume | Final Concentration |
| 5mg | 0.5mL | 10mg/mL |
| 5mg | 1mL | 5mg/mL |
| 5mg | 2mL | 2.5mg/mL |
| 5mg | 2.5mL | 2mg/mL |
| 5mg | 5mL | 1mg/mL |
| 5mg | 10mL | 0.5mg/mL |
If a researcher adds 1mL of a suitable validated research solvent to a 5mg vial, the resulting concentration is 5mg/mL.
This calculation is for research concentration planning only. It is not a human or animal dosing example.
No. SLU-PP-332 may appear in peptide research catalogues, but it is more accurately described as a synthetic small-molecule research compound.
SLU-PP-332 is commonly studied as an agonist of estrogen-related receptors ERRα, ERRβ and ERRγ. These nuclear receptors are involved in mitochondrial metabolism and energy pathway research.
It is described as exercise-mimetic in research because preclinical studies suggest it can activate aerobic exercise-like gene expression programmes in skeletal muscle models. This does not mean it is an exercise replacement for humans.
No. This product is supplied for laboratory research use only. It should not be described as approved for therapeutic, metabolic, body enhancement, weight loss, exercise replacement or injectable use.
No. This product should not be promoted or used for weight loss, endurance, exercise replacement, performance enhancement or any human health purpose.
A Certificate of Analysis provides batch-level testing information. It helps researchers verify product identity, purity and quality documentation before use in a research setting.
| Resource | Why It Is Useful |
| PubChem SLU-PP-332 compound profile | Useful background on molecular formula, compound identity and chemical data. |
| Tocris SLU-PP-332 technical profile | Useful technical reference for ERR agonist activity and EC50 values. |
| Cayman Chemical SLU-PP-332 profile | Useful supplier-level technical reference for ERRα, ERRβ and ERRγ agonist activity. |
Research Use Only: SLU-PP-332 5mg is supplied strictly for laboratory research purposes. It is not intended for human or animal consumption, injection, therapeutic use, cosmetic use, diagnostic use, weight loss, exercise replacement, metabolic treatment, athletic performance or body enhancement. Information on this page is provided for research education and product handling context only. Always follow applicable laws, institutional procedures, supplier documentation, SDS guidance and qualified laboratory protocols.
